fr   en
Clinical Studies
Phase :    
Announcement :   
Select a Pharma :
Select a product :
Select a disease :
Choose date:
[<<]      «      44   |   45   |   46   |   47   |   48   |   49   |   50   |   51   |   52   |   53   |   54      »      [57]
Date Phase Anouncement Biotech Pharma Product Disease Country Other
2007-06-15 I Launch Neose (USA) Novo Nordisk (Denmark) recombinant active Factor VII (long-acting glycopegylated factor) Prevention of bleeding during surgery or invasive procedures in patients with congenital haemophilia with inhibitors to coagulation factors VIII or IX   See details
2007-06-15 II Result Genmab (Denmark) GSK (UK) HuMax-CD20® (ofatumumab) rheumatoid arthritis Denmark, France, Hungary, Poland, United Kingdom and USA See details
2007-06-14 II Launch Genmab (Denmark) GSK (UK) ofatumumab (monoclonal antibody targeting a unique epitope of the CD-20 receptor on the surface of B-cells) non-Hodgkin’s lymphoma (NHL).   See details
2007-06-13 II Launch Chroma Therapeutics (UK)   CHR-2797 non-small cell lung cancer USA See details
2007-06-12 II Launch 7TM Pharma (Denmark)   obinepitide (TM30338) obesity Sweden See details
2007-06-07 III Launch Active Biotech (Sweden) Teva Pharmaceutical (Israel) laquinimod remitting multiple sclerosis USA, Europe and other undisclosed countries See details
2007-06-06 II Result Oxford Biomedica (GB) Sanofi-Aventis (France) Trovax® (MVA 5T4) metastatic kidney cancer   See details
2007-06-06 II Launch Movetis (Belgium)   M002 (selective vasopressin antagonist) cirrhosis-related ascites   See details
2007-06-04 II Result Micromet (Germany/USA)   adecatumumab (MT201 - fully human monoclonal antibody targeting tumor cells overexpressing the epithelial cell adhesion molecule EpCAM) metastatic breast cancer   See details
2007-06-01 III Launch Antisoma (UK)   Amonafide (AS1413 - DNA intercalating agent and inhibitor of topoisomerase II) acute myeloid leukemia (AML) USA, Australia, Argentina, Austria, Belgium, Canada, Chile, Czech Republic, Estonia, France, Germany, Hungary, Israel, Italy, Korea, Poland, Romania, Russian Federation, Spain, Taïwan, Ukraine, UK See details
2007-05-31 I Result LifeCycle Pharma (Denmark)   LCP-Tacro (a tacrolimus formulation) prevention of graft rejection   See details
2007-05-31 I-II Launch Cytheris (France)   CYT107 (recombinant glycosylated interleukin 7) metastatic melanoma or advanced renal carcinoma USA See details
2007-05-31 I-II Launch Cytheris (France)   CYT107 (recombinant glycosylated interleukin-7) hepatitis C France, Switzerland See details
2007-05-29 II Launch Oncolytics (Canada)   Reolysin® (reovirus, in combination with paclitaxel and carboplatin cancer (melanoma, lung cancer, ovarian cancer, head and neck cancer) United Kingdom See details
2007-05-24 I Launch Neurosearch (Denmark) Abbott (USA) ABT-107 (nicotinic receptor modulator) CNS diseases, including cognitive impairment   See details
[<<]      «      44   |   45   |   46   |   47   |   48   |   49   |   50   |   51   |   52   |   53   |   54      »      [57]